Sulphorhodamine B assay for measuring proliferation of a pigmented melanocyte cell line and its application to the evaluation of crude drugs used in the treatment of vitiligo

Journal of Ethnopharmacology

Volumn 66, Issue 2, 1999, Pages 141-150

  Lin, Zhi Xiu ^a   Hoult, J R S ^b   Raman, Amala ^b  

^a Institute of Chinese Medicine   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Herbal screening; Melan a cell line; Melanocyte; Proliferation; SRB assay; Vitiligo

Indexed keywords

ASTRAGALUS EXTRACT; CITRUS RETICULATA EXTRACT; DICTAMNUS DASYCARPUS EXTRACT; OPHIOPOGON JAPONICUS EXTRACT; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; PORIA COCOS EXTRACT; RHODAMINE; SULFORHODAMINE B; TRIBULUS TERRESTRIS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; DRUG SCREENING; EXTRACTION; MELANOCYTE; MOUSE; NONHUMAN; OPTICAL DENSITY; PHYTOCHEMISTRY; VITILIGO;

ANIMALS; CELL DIVISION; CELL LINE; DRUG EVALUATION, PRECLINICAL; MELANINS; MELANOCYTES; MICE; PHYTOTHERAPY; PIGMENTATION; PLANT EXTRACTS; PLANTS, MEDICINAL; REPRODUCIBILITY OF RESULTS; RHODAMINES; VITILIGO;

EID: 0345620928     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(98)00199-8     Document Type: Article

References (26)

1. Anon, 1985. Validation of Compendial Assays - Guidelines, United States Pharmacopeial Convention, Rockville, MD, 1985.
2. Anon Analytical Methods Committee: Uses (proper and improper) of correlation coefficients. Analyst. 113:1988;1469-1471.
3. Anon Analytical Methods Committee: Is my calibration linear? Analyst. 119:1994;2363-2366.
4. Bennett D.C., Cooper P.J., Hart I.R. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. International Journal of Cancer. 39:1987;414-418.
5. Bennett D.C., Cooper P.J., Dexter T.J., Devlin L.M., Heasman J., Nester B. Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development. 105:1989;379-385.
6. Cui J., Shen L., Wang G. Role of hair follicles in the repigmentation of vitiligo. Journal of Investigative Dermatology. 97:1991;410-416.
7. Dooley T.P., Gadwood R.C., Kilgore K., Thomasco L.M. Development of an in vitro primary screen for skin depigmentation and anti-melanoma agents. Skin Pharmacology. 7:1994;188-200.
8. Griffon G., Merlin J.L., Marchal C. Comparison of sulforhodamine B, tetrazolium and clonogenic assays for in vitro radiosensitivity testing in human ovarian cell lines. Anti-Cancer Drugs. 6:1995;115-123.
9. Haselsberger K., Perterson D.C., Thomas D.G.T., Darling J.L. Assay of anticancer drugs in tissue-culture - comparison of a tetrazolium-based assay and a protein-binding dye assay in short-term cultures derived from human-malignant glioma. Anti-Cancer Drugs. 7:1996;331-338.
10. Hori, K., Mishima, Y., Hayashiba, K., 1986. Antimelanosome associated monoclonal antibody-positive dendritic cells in the vitiligo epidermis. 37th Annual Meeting of Middle Japan Dermatology Society, Toyama, September, pp. 27-28.
11. Horikawa T., Norris D., Johnson T., Zekman T., Dunscomb N., Bennion S., Jacdson R., Morelli J. Dopa-negative melanocytes in the outer root sheath of human hair follicles express permelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2. Journal of Investigative Dermatology. 106:1996;28-35.
12. 14C (U)-L-tyrosine incorporation into melanin. Journal of Investigative Dermatology. 87:1982;243-252.
13. Keepers Y.P., Pizao P.E., Peters G.J., Vanarkotte J., Winograd B., Pinedo H.M. Comparison of the sulforhodamine-B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. European Journal of Cancer. 27:1991;897-900.
14. LePoole I., Vanden W., Westerhof W., Dutrieux R., Das P. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. Journal of Investigative Dermatology. 100:1993;816-822.
15. Ortonne J.P., Bose S. Vitiligo: where do we stand? Pigment Cell Research. 6:1993;61-72.
16. Ortonne J., MacDonald D., Micoud A., Thivolet J. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. British Journal of Dermatology. 101:1979;1-12.
17. Ortonne J.P., Mosher D.B., Fitzpatrick T.B. Vitiligo and Other Hypomelanoses of Hair and Skin. 1983;222 Plenum Medical, New York.
18. Perez R.P., Godwin A.K., Handel L.M., Hamilton T.C. A comparison of clonogenic, microtetrazolium and sulforhodamine-B assays for determination of cisplatin cytotoxicity in human ovarian-carcinoma cell-lines. European Journal of Cancer. 29A:1993;395-399.
19. Raman A., Lin Z. Screening plant extracts for the treatment of vitiligo. Conference Proceedings: Active Ingredients, Paris, France, 13-14 November 1996. 1996;203-221 Verlag für chemische Industrie, H. Ziolkowsky, Augsburg, Germany.
20. Raman A., Lin Z., Sviderskaya E., Kowalska D. Investigation of the effect of Angelica sinensis root extract on the proliferation of melanocytes in culture. Journal of Ethnopharmacology. 54:1996;165-170.
21. Rao J., Otto W. Fluorimetric DNA assay for cell growth estimation. Analytical Biochemistry. 207:1992;186-192.
22. Rubinstein L.V., Shoemaker R.H., Paull K.D., Simon R.M., Tosini S., Skehan P., Scudiero K.A., Monks A., Boyd M.R. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. Journal of the National Cancer Institute. 82:1990;1113-1118.
23. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bodesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute. 82:1990;1107-1112.
24. Staricco R. Amelanotic melanocytes in the outer root sheath of human hair follicle. Journal of Investigative Dermatology. 33:1959;295-297.
25. Staricco R. The melanocytes and the hair follicle. Journal of Investigative Dermatology. 35:1960;185-194.
26. Wen L., Peakman M., Lobo-Yeo A., McFarlane B., Mowat A., Meli-Vergani G., Vergani D. T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis. The Lancet. 336:1990;1527-1530.